Table 4

Univariable and multivariable Cox regression analysis of risk factors associated with overall survival

 UnivariableMultivariable*Multivariable†
HRPHRPHRP
Male sex1.23 (1.03, 1.47)0.021n.a.0.351n.a.0.478
Age > 60 years1.30 (1.14, 1.49)< 0.001n.a.0.066n.a.0.068
ASA grade > II1.27 (1.05, 1.53)0.016n.a.0.247n.a.0.314
HBV-positive1.30 (1.13, 1.49)< 0.001n.a.0.256n.a.0.284
Cirrhosis1.14 (0.99, 1.31)0.0681.33 (1.10, 1.61)0.0031.31 (1.08, 1.58)0.005
Child–Pugh grade B1.94 (1.57, 2.39)< 0.0011.87 (1.47, 2.37)< 0.0011.82 (1.43, 2.31)< 0.001
Preoperative AFP level (ng/ml)
 ≤ 1001.00 (reference)1.00 (reference)
 100–10001.96 (1.68, 2.29)< 0.0011.68 (1.40, 2.02)< 0.001
 > 10001.74 (1.47, 2.05)< 0.0011.36 (1.11, 1.66)0.003
Beyond Milan criteria†1.97 (1.72, 2.25)< 0.0011.52 (1.28, 1.81)< 0.001
Beyond AFP model*2.02 (1.77, 2.32)< 0.0011.54 (1.30, 1.83)< 0.001
Microvascular invasion1.82 (1.59, 2.07)< 0.0011.43 (1.20, 1.70)< 0.0011.47 (1.24, 1.74)< 0.001
Satellite nodules1.95 (1.66, 2.28)< 0.0011.63 (1.34, 1.97)< 0.0011.51 (1.24, 1.83)< 0.001
Incomplete tumour encapsulation1.79 (1.56, 2.06)< 0.0011.36 (1.15, 1.61)< 0.0011.37 (1.16, 1.63)< 0.001
Poor tumour differentiation1.34 (1.17, 1.54)< 0.001n.a.0.318n.a.0.137
Intraoperative blood loss > 600 ml1.74 (1.44, 2.11)< 0.001n.a.0.950n.a.0.759
Intraoperative blood transfusion1.92 (1.63, 2.26)< 0.0011.54 (1.27, 1.86)< 0.0011.50 (1.24, 1.82)1.499
Non-anatomical resection1.01 (0.88, 1.15)0.912
Major hepatectomy1.53 (1.31, 1.79)< 0.001n.a.0.747n.a.0.506
Narrow resection margin (< 1 cm)1.76 (1.53, 2.01)< 0.0011.97 (1.68, 2.31)< 0.0011.86 (1.58, 2.19)< 0.001
 UnivariableMultivariable*Multivariable†
HRPHRPHRP
Male sex1.23 (1.03, 1.47)0.021n.a.0.351n.a.0.478
Age > 60 years1.30 (1.14, 1.49)< 0.001n.a.0.066n.a.0.068
ASA grade > II1.27 (1.05, 1.53)0.016n.a.0.247n.a.0.314
HBV-positive1.30 (1.13, 1.49)< 0.001n.a.0.256n.a.0.284
Cirrhosis1.14 (0.99, 1.31)0.0681.33 (1.10, 1.61)0.0031.31 (1.08, 1.58)0.005
Child–Pugh grade B1.94 (1.57, 2.39)< 0.0011.87 (1.47, 2.37)< 0.0011.82 (1.43, 2.31)< 0.001
Preoperative AFP level (ng/ml)
 ≤ 1001.00 (reference)1.00 (reference)
 100–10001.96 (1.68, 2.29)< 0.0011.68 (1.40, 2.02)< 0.001
 > 10001.74 (1.47, 2.05)< 0.0011.36 (1.11, 1.66)0.003
Beyond Milan criteria†1.97 (1.72, 2.25)< 0.0011.52 (1.28, 1.81)< 0.001
Beyond AFP model*2.02 (1.77, 2.32)< 0.0011.54 (1.30, 1.83)< 0.001
Microvascular invasion1.82 (1.59, 2.07)< 0.0011.43 (1.20, 1.70)< 0.0011.47 (1.24, 1.74)< 0.001
Satellite nodules1.95 (1.66, 2.28)< 0.0011.63 (1.34, 1.97)< 0.0011.51 (1.24, 1.83)< 0.001
Incomplete tumour encapsulation1.79 (1.56, 2.06)< 0.0011.36 (1.15, 1.61)< 0.0011.37 (1.16, 1.63)< 0.001
Poor tumour differentiation1.34 (1.17, 1.54)< 0.001n.a.0.318n.a.0.137
Intraoperative blood loss > 600 ml1.74 (1.44, 2.11)< 0.001n.a.0.950n.a.0.759
Intraoperative blood transfusion1.92 (1.63, 2.26)< 0.0011.54 (1.27, 1.86)< 0.0011.50 (1.24, 1.82)1.499
Non-anatomical resection1.01 (0.88, 1.15)0.912
Major hepatectomy1.53 (1.31, 1.79)< 0.001n.a.0.747n.a.0.506
Narrow resection margin (< 1 cm)1.76 (1.53, 2.01)< 0.0011.97 (1.68, 2.31)< 0.0011.86 (1.58, 2.19)< 0.001

Values in parentheses are 95% confidence intervals. *‘Beyond α-fetoprotein (AFP) model’ variable was entered into the multivariable analysis. †‘Preoperative AFP level’ and ‘Beyond Milan criteria’ variables were entered into the multivariable analysis. HR, hazard ratio; n.a., not available; ASA, American Society of Anesthesiologists; HBV, hepatitis B virus.

Table 4

Univariable and multivariable Cox regression analysis of risk factors associated with overall survival

 UnivariableMultivariable*Multivariable†
HRPHRPHRP
Male sex1.23 (1.03, 1.47)0.021n.a.0.351n.a.0.478
Age > 60 years1.30 (1.14, 1.49)< 0.001n.a.0.066n.a.0.068
ASA grade > II1.27 (1.05, 1.53)0.016n.a.0.247n.a.0.314
HBV-positive1.30 (1.13, 1.49)< 0.001n.a.0.256n.a.0.284
Cirrhosis1.14 (0.99, 1.31)0.0681.33 (1.10, 1.61)0.0031.31 (1.08, 1.58)0.005
Child–Pugh grade B1.94 (1.57, 2.39)< 0.0011.87 (1.47, 2.37)< 0.0011.82 (1.43, 2.31)< 0.001
Preoperative AFP level (ng/ml)
 ≤ 1001.00 (reference)1.00 (reference)
 100–10001.96 (1.68, 2.29)< 0.0011.68 (1.40, 2.02)< 0.001
 > 10001.74 (1.47, 2.05)< 0.0011.36 (1.11, 1.66)0.003
Beyond Milan criteria†1.97 (1.72, 2.25)< 0.0011.52 (1.28, 1.81)< 0.001
Beyond AFP model*2.02 (1.77, 2.32)< 0.0011.54 (1.30, 1.83)< 0.001
Microvascular invasion1.82 (1.59, 2.07)< 0.0011.43 (1.20, 1.70)< 0.0011.47 (1.24, 1.74)< 0.001
Satellite nodules1.95 (1.66, 2.28)< 0.0011.63 (1.34, 1.97)< 0.0011.51 (1.24, 1.83)< 0.001
Incomplete tumour encapsulation1.79 (1.56, 2.06)< 0.0011.36 (1.15, 1.61)< 0.0011.37 (1.16, 1.63)< 0.001
Poor tumour differentiation1.34 (1.17, 1.54)< 0.001n.a.0.318n.a.0.137
Intraoperative blood loss > 600 ml1.74 (1.44, 2.11)< 0.001n.a.0.950n.a.0.759
Intraoperative blood transfusion1.92 (1.63, 2.26)< 0.0011.54 (1.27, 1.86)< 0.0011.50 (1.24, 1.82)1.499
Non-anatomical resection1.01 (0.88, 1.15)0.912
Major hepatectomy1.53 (1.31, 1.79)< 0.001n.a.0.747n.a.0.506
Narrow resection margin (< 1 cm)1.76 (1.53, 2.01)< 0.0011.97 (1.68, 2.31)< 0.0011.86 (1.58, 2.19)< 0.001
 UnivariableMultivariable*Multivariable†
HRPHRPHRP
Male sex1.23 (1.03, 1.47)0.021n.a.0.351n.a.0.478
Age > 60 years1.30 (1.14, 1.49)< 0.001n.a.0.066n.a.0.068
ASA grade > II1.27 (1.05, 1.53)0.016n.a.0.247n.a.0.314
HBV-positive1.30 (1.13, 1.49)< 0.001n.a.0.256n.a.0.284
Cirrhosis1.14 (0.99, 1.31)0.0681.33 (1.10, 1.61)0.0031.31 (1.08, 1.58)0.005
Child–Pugh grade B1.94 (1.57, 2.39)< 0.0011.87 (1.47, 2.37)< 0.0011.82 (1.43, 2.31)< 0.001
Preoperative AFP level (ng/ml)
 ≤ 1001.00 (reference)1.00 (reference)
 100–10001.96 (1.68, 2.29)< 0.0011.68 (1.40, 2.02)< 0.001
 > 10001.74 (1.47, 2.05)< 0.0011.36 (1.11, 1.66)0.003
Beyond Milan criteria†1.97 (1.72, 2.25)< 0.0011.52 (1.28, 1.81)< 0.001
Beyond AFP model*2.02 (1.77, 2.32)< 0.0011.54 (1.30, 1.83)< 0.001
Microvascular invasion1.82 (1.59, 2.07)< 0.0011.43 (1.20, 1.70)< 0.0011.47 (1.24, 1.74)< 0.001
Satellite nodules1.95 (1.66, 2.28)< 0.0011.63 (1.34, 1.97)< 0.0011.51 (1.24, 1.83)< 0.001
Incomplete tumour encapsulation1.79 (1.56, 2.06)< 0.0011.36 (1.15, 1.61)< 0.0011.37 (1.16, 1.63)< 0.001
Poor tumour differentiation1.34 (1.17, 1.54)< 0.001n.a.0.318n.a.0.137
Intraoperative blood loss > 600 ml1.74 (1.44, 2.11)< 0.001n.a.0.950n.a.0.759
Intraoperative blood transfusion1.92 (1.63, 2.26)< 0.0011.54 (1.27, 1.86)< 0.0011.50 (1.24, 1.82)1.499
Non-anatomical resection1.01 (0.88, 1.15)0.912
Major hepatectomy1.53 (1.31, 1.79)< 0.001n.a.0.747n.a.0.506
Narrow resection margin (< 1 cm)1.76 (1.53, 2.01)< 0.0011.97 (1.68, 2.31)< 0.0011.86 (1.58, 2.19)< 0.001

Values in parentheses are 95% confidence intervals. *‘Beyond α-fetoprotein (AFP) model’ variable was entered into the multivariable analysis. †‘Preoperative AFP level’ and ‘Beyond Milan criteria’ variables were entered into the multivariable analysis. HR, hazard ratio; n.a., not available; ASA, American Society of Anesthesiologists; HBV, hepatitis B virus.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close